Chercheur émérite, Institut Douglas
remi_dot_quirion_At_mcgill_dot_ca |
2002
Auld D. S., Kornecook T. J., , Quirion R. (2002). Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies, Prog Neurobiol, 68(3), 209-45.
, Quirion R. (2002). Natural extracts as possible protective agents of brain aging, Neurobiol Aging, 23(5), 891-97.
, Quirion R. (2002). EGb 761 is a neuroprotective agent against beta-amyloid toxicity, Cell Mol Biol (Noisy-le-grand), 48(6), 693-7.
Belanger S., Ma W., Chabot J. G., Quirion R. (2002). Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates, Neuroscience, 115(2), 441-53.
Dumont Y., Redrobe J. P., Quirion R. (2002). Neuropeptide Y receptors . Dans Pangalos M. N. & Davies C. H. (Éds.) , Understanding G protein-coupled receptors and their role in the CNS (pp. 372-401). Oxford University Press.
Geiger J. D., Legace-Wiens P., , Quirion R. (2002). Creatine and Gingko Biloba Use in Sports and Health: A Knowledge Utilization Approach . Dans Mattson M. P. (Éd.) , Diet-Brain Connections: Impact on Memory, Mood, Aging and Disease (pp. 135-157). Kluwer Academic Publishers.
Kask A., Harro J., von Horsten S., Redrobe J. P., Dumont Y., Quirion R. (2002). The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y, Neurosci Biobehav Rev, 26(3), 259-83.
Law A., O'Donnell J., Gauthier S., Quirion R. (2002). Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats, Neuroscience, 112(2), 267-75.
Ma W., Quirion R. (2002). Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus, Pain, 99(1-2), 175-84.
Mennicken F., Chabot J. G., Quirion R. (2002). Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain, Glia, 37(2), 124-38.
Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., Dumont Y., Quirion R., Detheux M., Parmentier M., Zajac J. M. (2002). Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists, Eur J Pharmacol, 451(3), 245-56.
Ossipov M. H., Zhang E. T., Carvajal C., Gardell L., Quirion R., Dumont Y., Lai J., Porreca F. (2002). Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y, J Neurosci, 22(22), 9858-67.
Poyner D. R., Sexton P. M., Marshall I., Smith D. M., Quirion R., Born W., Muff R., Fischer J. A., Foord S. M. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors, Pharmacol Rev, 54(2), 233-46.
Quirion R. (2002). A Canadian experiment: the Institute of Neurosciences, Mental Health and Addiction. How to link up the brain via a virtual institute, Trends Neurosci, 25(5), 268-70.
Quirion R., Björklund A., Hökfelt T. (2002). Peptide Receptors Part II . Elsevier.
Redrobe J. P., Calo G., Regoli D., Quirion R. (2002). Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test, Naunyn Schmiedebergs Arch Pharmacol, 365(2), 164-7.
Redrobe J. P., Dumont Y., Fournier A., Quirion R. (2002). The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test, Neuropsychopharmacology, 26(5), 615-24.
Redrobe J. P., Dumont Y., Quirion R. (2002). Neuropeptide Y (NPY) and depression: from animal studies to the human condition, Life Sci, 71(25), 2921-37.
Seto D., Zheng W. H., McNicoll A., Collier B., Quirion R., Kar S. (2002). Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects, Neuroscience, 115(2), 603-12.
Trang T., Sutak M., Quirion R., Jhamandas K. (2002). The role of spinal neuropeptides and prostaglandins in opioid physical dependence, Br J Pharmacol, 136(1), 37-48.